The Bolus Dose of Dexmedetomidine (ED50) That Avoids Hemodynamic Compromise in Children

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions
Hemodynamic Instability
Interventions
DRUG

Dexmedetomidine

The bolus dose of dexmedetomidine given will range from 0.25-2.0 mcg/kg and will be based on the up-and-down method, such that subject 1 will receive 0.5 mcg/kg and if no significant hemodynamic changes occur (heart rate decrease \< 20% or blood pressure decrease/increase \< 20%) the does will be increased by 0.25 mcg/kg for the subsequent subject. If significant hemodynamic changes occur (HR decrease \>/= 20% or SBP/DBP/MAP decrease or increase \>/= 20%) the dose will be decreased by 0.25 mcg/kg for the subsequent subject. Each subject will be observed for 10 minutes following the dexmedetomidine bolus.

Trial Locations (1)

V6H 3V4

British Columbia Children's Hospital, Vancouver

All Listed Sponsors
lead

University of British Columbia

OTHER

NCT01498380 - The Bolus Dose of Dexmedetomidine (ED50) That Avoids Hemodynamic Compromise in Children | Biotech Hunter | Biotech Hunter